3/30/2023 0 Comments Economics of halo redditSVB Leerink also issued estimates for Halozyme Therapeutics' Q4 2023 earnings at $0.77 EPS, FY2023 earnings at $2.42 EPS, Q1 2024 earnings at $0.72 EPS, Q4 2024 earnings at $0.79 EPS, FY2024 earnings at $3.12 EPS, FY2025 earnings at $4.47 EPS and FY2026 earnings at $6.01 EPS.Ī number of other research firms have also issued reports on HALO. The consensus estimate for Halozyme Therapeutics' current full-year earnings is $2.63 per share. SVB Leerink currently has a "Outperform" rating and a $61.00 price objective on the stock. Risinger now forecasts that the biopharmaceutical company will post earnings of $0.67 per share for the quarter, up from their previous forecast of $0.65. ( NASDAQ:HALO - Get Rating) - Investment analysts at SVB Leerink lifted their Q3 2023 earnings per share estimates for Halozyme Therapeutics in a research report issued to clients and investors on Wednesday, February 22nd. Solo Brands May Remind Investors Why Cash is King.FuelCell Energy Gains Traction, Shares Surge.How to Buy High Yielding Dividend Stocks.Can Investors Trust Consumers to Lift American Outdoor Brands?.Three Staples Stocks With Double-Digit Upside Ahead.2 Offshore Drilling Stocks Set to Extract Big Profits.What the SVB Financial Collapse Means for U.S.NVIDIA Stock Confirms Reversal Headed Higher?.Has Rivian Stock Reached a Buyable Bottom?.Rocket Lab Stock Could Go to the Moon, Patience Required.The Trader's Guide to Equities Research.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |